Nova Patents
ATE433775T1

Insulin delivery system with sensor

Abstract

A closed loop therapy system for controlling a concentration of a substance, such as blood glucose concentration, in the body of a user. The system and method employ a sensor system that measures a glucose level in the body, a controller that uses the measured glucose levels to generate an output that can be used to automatically or manually control an intradermal insulin infusion system to set a constant or time-varying profile of target blood glucose concentrations in a user, and then infuse an appropriate amount of insulin into the body of the user so as to reach and maintain the target values of the blood glucose concentration.

Term

Term ended

Projected expiry passed 14 October 2023, 2.9 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

20 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
41755902United States of AmericaP
43223302United States of AmericaP
0332506United States of AmericaW

Members20

Family members, oldest first
DocumentOfficeKind
CA2505639A1CanadaA1
US2004152622A1United States of AmericaA1
WO2005061041A1World Intellectual Property Organization (WIPO)A1
AU2003287073A1AustraliaA1
EP1575656A1European Patent Office (EPO)A1
JP2006510467AJapanA
KR20060057522ARepublic of KoreaA
US7060059B2United States of AmericaB2
CN1859943AChinaA
EP1575656A4European Patent Office (EPO)A4
AU2003287073B2AustraliaB2
EP1575656B1European Patent Office (EPO)B1
AT433775TAustriaT
ATE433775T1This recordAustriaT1
DE60328039D1GermanyD1
ES2328806T3SpainT3
CN1859943BChinaB
JP4599296B2JapanB2
CA2505639CCanadaC
KR101226540B1Republic of KoreaB1